51³Ô¹ÏºÚÁÏ

The University of California, Davis, will play a key role in a new worldwide effort to create a so-called "knockout" mutant mouse for each of the approximately 20,000 genes in the mouse genome. These mice can be used to study the function of specific genes and to create models of human disease, ranging from growth and development to cancer, obesity, diabetes and heart disease.

The National Institutes of Health has awarded a five-year cooperative agreement worth approximately $23 million to a consortium of the Children's Hospital Oakland Research Institute; 51³Ô¹ÏºÚÁÏ Davis; and the Wellcome Trust Sanger Institute, England.

The group plans to create lines of embryonic mouse stem cells in which 5,000 individual genes will be systematically turned off, or "knocked out." Those embryonic stem cells will then be used to breed live mice that lack those genes.

"This award places 51³Ô¹ÏºÚÁÏ Davis and its School of Veterinary Medicine front and center as a resource for genetically altered mice," said Bennie Osburn, dean of the school. "Our understanding of animal and human disease will progress more quickly as these essential mouse models become more available to scientists."

The 51³Ô¹ÏºÚÁÏ Davis Mouse Biology Program was established in 1997 to support and expand research by campus scientists using genetically altered mice. The program is already the largest of the major sites in the NIH-funded Mutant Mouse Regional Resource Centers network, where researchers can deposit gene-modified mice that they have created and request specific mice for noncommercial research purposes.

Scientists have been making knockout mice since 1988, but so far these cover only about 5,000 genes, or about 25 percent of the mouse genome, said Kent Lloyd, a principal investigator on the grant and associate dean for research at the School of Veterinary Medicine.

"The technology is now here to do this on a high-throughput basis," Lloyd said. "Within five years, through this and related projects around the world, scientists will have access to knockouts of the whole mouse genome."

Ten thousand genes that are most closely shared between mice and humans are a high priority for the NIH. Studying how those genes work in mice can give insights into human health and disease.

Scientists at Children's Hospital Oakland Research Institute will make the altered DNA for the mice; researchers at the Sanger Institute will insert that DNA into mouse embryonic stem cells; and 51³Ô¹ÏºÚÁÏ Davis scientists will use those cells to breed the mice and check that the correct genes are knocked out.

The mice created by the NIH program will be available to other researchers through a public repository, which will be funded under a separate grant from NIH.

In addition to Lloyd, the leaders of the consortium are Pieter deJong of Children's Hospital, and Allan Bradley and William Skarnes at the Sanger Institute.

The grant is one of several announced by the NIH Sept. 7 to launch the Knockout Mouse Project. The others include a second, complementary grant to generate knockout mice, and smaller grants for a data coordination center and research on improving methods for making gene-altered mice.

The NIH also announced that the U.S. program will collaborate with similar large-scale efforts in Canada and Europe. The programs will share information, coordinate efforts and aim to create mutations for each of the 20,000 genes in the mouse genome, according to information released by the NIH.